NLRC5/MHC class I transactivator is a target for immune evasion in cancer

Sayuri Yoshihama, Jason Roszik, Isaac Downs, Torsten B. Meissner, Saptha Vijayan, Bjoern Chapuy, Tabasum Sidiq, Margaret A. Shipp, Gregory A. Lizee, Koichi S. Kobayashi

Research output: Contribution to journalArticlepeer-review

182 Scopus citations

Fingerprint

Dive into the research topics of 'NLRC5/MHC class I transactivator is a target for immune evasion in cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences